Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Department of Urology, Tokyo Women's Medical University Adachi Medical Center, 4-33-1 Kouhoku, Adachi-ku, Tokyo, Japan.
Int J Clin Oncol. 2022 Oct;27(10):1624-1631. doi: 10.1007/s10147-022-02222-9. Epub 2022 Jul 25.
Cancer development in adolescents and young adults (AYAs) has elicited recent interest. We investigated the surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy (RAPN) for renal cell carcinoma (RCC) in AYAs.
We retrospectively reviewed the medical records of 1023 patients with clinical stage I RCC who underwent RAPN before January 2021. Patients were divided into two groups: AYAs (aged 18-39 years) and non-AYAs (aged 40-89 years). The trifecta criteria, defined as a negative surgical margin, no perioperative complications (Clavien-Dindo grade > 2), and preserved postoperative renal function (1-year postoperative estimated glomerular filtration rate > 90% of baseline), were used to compare outcomes. We performed 1:1 propensity-score matching on the patient cohort.
There were initially 125 and 898 patients in the AYAs and non-AYAs groups, respectively, and 108 patients were included in each group after propensity score matching. There were no significant differences in surgical factors (operation time, clamping ischemia time, estimated blood loss, length of hospital stay, surgical complication rate) or renal function in the early postoperative period. The mean postoperative renal function was better (p = 0.0200) and the decrease in estimated glomerular filtration rate was lower (p = 0.0026) in AYAs than in non-AYAs 12 months postoperatively. The trifecta achievement rates in the AYAs and non-AYAs groups were significantly different (67.6% and 53.7%, respectively, p = 0.0220).
Although there was no difference in surgical burden between the groups, the estimated glomerular filtration rate was better preserved in AYAs than in non-AYAs at 6 and 12 months post-RAPN.
青少年和年轻成年人(AYAs)的癌症发展引起了最近的关注。我们研究了机器人辅助腹腔镜部分肾切除术(RAPN)治疗 AYAs 肾细胞癌(RCC)的手术和功能结果。
我们回顾性分析了 2021 年 1 月前接受 RAPN 治疗的 1023 例临床 I 期 RCC 患者的病历。患者分为两组:AYAs(18-39 岁)和非 AYAs(40-89 岁)。采用 trifecta 标准(定义为切缘阴性、无围手术期并发症(Clavien-Dindo 分级>2)和保留术后肾功能(术后 1 年估算肾小球滤过率>基线的 90%)比较结果。我们对患者队列进行了 1:1 倾向评分匹配。
最初 AYAs 组和非 AYAs 组分别有 125 例和 898 例患者,匹配后每组各有 108 例患者。两组在手术因素(手术时间、夹闭缺血时间、估计失血量、住院时间、手术并发症发生率)或术后早期肾功能方面无显著差异。术后平均肾功能更好(p=0.0200),术后 12 个月估算肾小球滤过率下降较低(p=0.0026),AYAs 优于非 AYAs。AYAs 组和非 AYAs 组 trifecta 达标率差异有统计学意义(分别为 67.6%和 53.7%,p=0.0220)。
虽然两组手术负担无差异,但与非 AYAs 相比,RAPN 后 6 个月和 12 个月时 AYAs 的估算肾小球滤过率保存更好。